Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 1Renal Cell Cancer Metastatic 1Carcinoma, Non-Small-Cell Lung 1Advanced Malignant Solid Tumors 1Advanced Gastric Cancer 1

Interventions

Paclitaxel 6apatinib 4camrelizumab 3S 1 (combination) 2Capecitabine 2130-nm albumin-bound paclitaxel 2vorolanib 1titanium silicide 1spartalizumab 1raltitrexed 1olaparib 1lobaplatin 1durvalumab 1Ramucirumab 1Oxaliplatin 1Gastrectomy 1Docetaxel 1Control Groups 1Cisplatin 1CF regimen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Advanced Gastric Cancer × vorolanib × Clear all
NCT03286244 2019-02-21

Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer

AnewPharma

Phase 1 Unknown
21 enrolled
Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡